BNP PARIBAS FINANCIAL MARKETS - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 48 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2019. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$2,524,217
+46.6%
91,723
+80.7%
0.00%
+50.0%
Q2 2023$1,722,185
-47.7%
50,757
-44.6%
0.00%
-60.0%
Q1 2023$3,295,156
+106.2%
91,583
+155.4%
0.01%
+150.0%
Q4 2022$1,598,369
-99.9%
35,862
-52.0%
0.00%
-33.3%
Q3 2022$2,101,813,000
+687.0%
74,771
+654.8%
0.00%
Q2 2022$267,066,000
+107.4%
9,906
+162.0%
0.00%
Q1 2022$128,781,000
-77.2%
3,781
-74.1%
0.00%
-100.0%
Q4 2021$563,758,000
+21.1%
14,590
+69.3%
0.00%0.0%
Q3 2021$465,394,000
+821.7%
8,620
+470.9%
0.00%
Q2 2021$50,494,000
+663.6%
1,510
+370.4%
0.00%
Q1 2021$6,613,000
+12377.4%
321
+10600.0%
0.00%
Q4 2020$53,000
+20.5%
30.0%0.00%
Q3 2020$44,000
+12.8%
30.0%0.00%
Q2 2020$39,000
-2.5%
3
-87.5%
0.00%
Q1 2020$40,000
-25.9%
240.0%0.00%
Q4 2019$54,000
-90.1%
24
-90.6%
0.00%
Q3 2019$545,000
-25.7%
256
-6.6%
0.00%
Q2 2019$734,0002740.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2019
NameSharesValueWeighting ↓
Kynam Capital Management, LP 2,600,000$88,218,00012.13%
Octagon Capital Advisors LP 759,898$25,783,3393.59%
TSP Capital Management Group, LLC 251,895$8,546,8003.08%
ACUTA CAPITAL PARTNERS, LLC 122,343$4,151,0982.81%
5AM Venture Management, LLC 310,270$10,527,4612.62%
COMMODORE CAPITAL LP 631,665$21,432,3932.41%
RTW INVESTMENTS, LP 3,463,201$117,506,4102.24%
Eversept Partners, LP 785,740$26,660,1582.23%
Redmile Group, LLC 1,696,004$57,545,4162.21%
Affinity Asset Advisors, LLC 87,031$2,952,9621.03%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders